Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-10 of 10 for your search:
Drug:
samarium Sm 153 lexidronam pentasodium
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase I/II Study of Samarium 153 and Autologous Bone Marrow Transplantation in Women With Stage IV Breast Cancer (Summary Last Modified 04/2002)
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
21-65
Sponsor:
Other
Protocol IDs:
LSU-97447
, NCI-V97-1341, NCT00003086
2.
Phase I/II Pilot Study of Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MAYO-MC0585
, MAYO-IRB-1586-05, MC0585, NCT00478075
3.
Phase I/II Pilot Study of Samarium Sm 153 Lexidronam Pentasodium in Combination With Zoledronic Acid or Pamidronate Disodium in Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Phase:
Phase II, Phase I
Type:
Supportive care, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC048B
, MAYO-IRB-261-05, MC048B, NCT00482378
4.
Phase I/II Study of Conditioning Regimen Comprising Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Patients With Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MAYO-MC9981
, MC9981, NCT00602706
5.
Phase II Study of Samarium Sm 153 Lexidronam Pentasodium (153Sm-lexidronam) in Combination with Total Androgen Blockade in Patients with Stage D2 Prostate Carcinoma (Summary Last Modified 06/98)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CYTOGEN-424Sm17
, NCI-V97-1255
6.
Phase II Study of High-Dose Samarium Sm 153 Lexidronam Pentasodium and Autologous Peripheral Blood Stem Cell Transplantation Followed By External-Beam Radiotherapy in Patients With Recurrent or Refractory, Metastatic, or Unresectable Osteosarcoma
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
13 to 50
Sponsor:
NCI
Protocol IDs:
JHOC-J0347
, J0347, JHOC-03090802, NCT00245011
7.
Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Phase:
Phase II
Type:
Behavioral study, Treatment
Status:
Closed
Age:
18 to 65
Sponsor:
Other
Protocol IDs:
2006-0349
, NCT00429507
8.
Phase I Study of 153Sm-EDTMP in Children with Refractory Malignancies and Painful Osseous Lesions (Summary Last Modified 07/97)
Phase:
Phase I
Type:
Supportive care, Treatment
Status:
Completed
Age:
over 5 to 25
Sponsor:
NCI
Protocol IDs:
NCI-95-C-0113A
9.
Phase I Study of Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
Phase:
Phase I
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
ONCOTHER-20051780
, ONCOTHER-424Sm35, CYTOGEN-ONCOTHER-20051780, NCT00316940
10.
Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer
Phase:
Phase I
Type:
Treatment
Status:
Completed
Age:
18 to 80
Sponsor:
Other
Protocol IDs:
J0467
, 04-09-03-03, NCT00559429
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute